Excess Sweating, Hyperhidrosis
Conditions
Brief summary
The purpose of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.
Detailed description
The objective of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.
Interventions
20% aluminum chloride hexahydrate
1% aluminum acetate
Sponsors
Study design
Eligibility
Inclusion criteria
* age 21-30 years * males and females * The subjects are in good health. * The subjects have willingness and the ability to understand and provide informed consent for participation in the study.
Exclusion criteria
* Subjects with primary hyperhidrosis * Subjects who are unable to withstand prolonged heat exposure or who have self-reported history of cardiovascular or respiratory disorders. * Subjects who are unable to give informed consent. * Subjects with mental illness. * Subjects who are pregnant or nursing. * Subjects with systemic or local skin disease and/or infection that may interfere with the conduct of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gravimetric analysis | 3 hours |
Secondary
| Measure | Time frame |
|---|---|
| Subject sweat assessment | 3 hours |
| HDSS | 3 hours |
Countries
United States